LambdaVision, an innovative biotech company developing a protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases, is advancing its commercialization efforts ...

The Global Diabetes Epidemic Diabetes poses a significant health challenge worldwide, with experts alarmed by its increasing prevalence. In India, the situation is particularly dire, earning the ...

Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.

Dim indoor light and prolonged close focus may be quietly fueling the global rise in nearsightedness.

Blurry vision isn’t always due to screen strain or ageing. Ophthalmologists warn it can signal vitamin deficiencies like A, ...

Prolonged near work in low luminance may accelerate myopia primarily by limiting retinal illumination through sustained accommodative miosis rather than by electronic screens per se.

“Most people first notice age-related changes to their eyesight in their forties when the lens inside becomes less flexible, ...

Paired with external glasses, a tiny chip that is surgically placed under the retina is helping people who are legally blind ...

Researchers from Harvard Medical School and Spark Therapeutics Inc. tested subretinal NRF2 gene therapy in dry AMD models to investigate whether it could relieve oxidative stress and inflammation.

We’ve been looking at the wrong part of the eye. New research shows the earliest signs of Alzheimer's are hidden at the very edges of the retina.

Company will debut five-year results from GALE study showing meaningful impact of early and continuous treatment with SYFOVRE® (pegcetacoplan ...